Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Z-pods® are a patented topical delivery platform developed by Zylö Therapeutics, utilizing engineered amorphous silica particles to encapsulate active ingredients. For acne treatment, these "Z-pods" are designed to target pores and hair follicles specifically, providing sustained release (over 24 hours) of anti-acne agents such as salicylic acid. The technology aims to improve the bioavailability and efficacy of topical compounds while potentially reducing irritation by controlling the release rate. Zylö Therapeutics operates as a platform technology provider, collaborating with cosmetic, over-the-counter (OTC), and pharmaceutical partners to integrate this technology into various acne products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on salicylic acid Z-pods.